Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ Recolector de Cienci...arrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
image/svg+xml Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Closed Access logo, derived from PLoS Open Access logo. This version with transparent background. http://commons.wikimedia.org/wiki/File:Closed_Access_logo_transparent.svg Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao
versions View all 1 versions
addClaim

Paciente de 60 años con diabetes, obesidad y psoriasis

Authors: Calzada Valle, A.; Moreno Verdejo, Fidel; Pérez Mairen, A. M.; Falcón Ortega, M.; García Contreras, R.; González Jiménez, M. D.; Calderón, Enrique J.; +1 Authors

Paciente de 60 años con diabetes, obesidad y psoriasis

Abstract

Mujer de 60 años con antecedentes personales de diabetes, obesidad y psoriasis que fue derivada desde Atención Primaria por mal control glucémico (Hb glicada: 7,3%). Se inició tratamiento con metformina 850 mg/12h y liraglutide 1,2 mg/sc/d, manteniéndose el mismo tratamiento que venía realizando para la psoriasis con corticoides tópicos y metrotexate. Tres meses tras el cambio de tratamiento se revisó en consultas objetivándose un óptimo control glucémico (Hb glicada 6,1%), reducción de 8,5 Kg de peso y mejoría de las lesiones cutáneas.

IX Reunión de Diabetes y Obesidad (30-31 de enero de 2015, Sevilla). Grupo de Diabetes y Obesidad de la Fundación Española de Medicina Interna.

No

  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    0
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
0
Average
Average
Average
Green